Wanle Hu

647 total citations
22 papers, 508 citations indexed

About

Wanle Hu is a scholar working on Oncology, Molecular Biology and Toxicology. According to data from OpenAlex, Wanle Hu has authored 22 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Toxicology. Recurrent topics in Wanle Hu's work include Cytokine Signaling Pathways and Interactions (8 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Cancer Mechanisms and Therapy (4 papers). Wanle Hu is often cited by papers focused on Cytokine Signaling Pathways and Interactions (8 papers), Bioactive Compounds and Antitumor Agents (6 papers) and Cancer Mechanisms and Therapy (4 papers). Wanle Hu collaborates with scholars based in China, United States and Ireland. Wanle Hu's co-authors include Changbao Liu, Chengguang Zhao, Xuanxuan Dai, Hailun Zheng, Guang Liang, Xiangyang Wang, Chun Jin, Youqun Xiang, Min Lu and Zhao Jin and has published in prestigious journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and Carbohydrate Polymers.

In The Last Decade

Wanle Hu

22 papers receiving 503 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wanle Hu China 15 219 149 76 58 58 22 508
Zhan‐Qi Cao China 10 275 1.3× 112 0.8× 104 1.4× 45 0.8× 36 0.6× 14 528
Leri S. Faried Japan 10 360 1.6× 110 0.7× 73 1.0× 37 0.6× 27 0.5× 13 588
Lianxin Liu China 9 268 1.2× 96 0.6× 87 1.1× 31 0.5× 51 0.9× 11 408
Grégory Tufo France 3 381 1.7× 104 0.7× 129 1.7× 53 0.9× 60 1.0× 3 583
Rishi K. Gara India 12 323 1.5× 98 0.7× 84 1.1× 23 0.4× 80 1.4× 12 594
Hareesh B. Nair United States 15 259 1.2× 224 1.5× 80 1.1× 47 0.8× 27 0.5× 48 800
Darko Castven Germany 10 229 1.0× 106 0.7× 114 1.5× 43 0.7× 19 0.3× 22 425
Sima Mansoori Derakhshan Iran 5 325 1.5× 69 0.5× 103 1.4× 58 1.0× 46 0.8× 22 533

Countries citing papers authored by Wanle Hu

Since Specialization
Citations

This map shows the geographic impact of Wanle Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wanle Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wanle Hu more than expected).

Fields of papers citing papers by Wanle Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wanle Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wanle Hu. The network helps show where Wanle Hu may publish in the future.

Co-authorship network of co-authors of Wanle Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Wanle Hu. A scholar is included among the top collaborators of Wanle Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wanle Hu. Wanle Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Limei, Xin You, Rong Chen, et al.. (2025). Thermosensitive poly (NVCL-co-GelMA) nanogels as a delivery platform for rectal administration of 5-ASA in ulcerative colitis. Chemical Engineering Journal. 512. 162442–162442. 1 indexed citations
2.
Jia, Erna, et al.. (2022). Injectable carboxymethyl chitosan-genipin hydrogels encapsulating tea tree oil for wound healing. Carbohydrate Polymers. 301(Pt B). 120348–120348. 53 indexed citations
3.
Hu, Wanle, et al.. (2021). lncRNA MCF2L-AS1/miR-105/ IL-1β Axis Regulates Colorectal Cancer Cell Oxaliplatin Resistance. Cancer Management and Research. Volume 13. 8685–8694. 9 indexed citations
4.
Zheng, Dandan, Yu Zhu, Lehe Yang, et al.. (2021). Cynaropicrin Shows Antitumor Progression Potential in Colorectal Cancer Through Mediation of the LIFR/STATs Axis. Frontiers in Cell and Developmental Biology. 8. 605184–605184. 17 indexed citations
5.
Hu, Wanle, et al.. (2020). Ethanol Extracted from Radix of Actinidia Chinensis Inhibits Human Colon Tumor Through Inhibiting Notch-signaling Pathway. Journal of Cancer. 12(3). 622–629. 8 indexed citations
6.
Yang, Lehe, Ying Bai, Dandan Zheng, et al.. (2020). Effect of the isoflavone corylin from cullen corylifolium on colorectal cancer growth, by targeting the STAT3 signaling pathway. Phytomedicine. 80. 153366–153366. 24 indexed citations
7.
Yang, Lehe, Hua Ye, Zhiping Li, et al.. (2020). Gracillin shows potent efficacy against colorectal cancer through inhibiting the STAT3 pathway. Journal of Cellular and Molecular Medicine. 25(2). 801–812. 18 indexed citations
8.
Zhou, Chong-Jun, Yifan Cheng, Linzhen Xie, et al.. (2019). Metabolic Syndrome, as Defined Based on Parameters Including Visceral Fat Area, Predicts Complications After Surgery for Rectal Cancer. Obesity Surgery. 30(1). 319–326. 19 indexed citations
9.
Zhuang, Yan, Ying Bai, Yan Hu, et al.. (2019). <p>Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway</p>. OncoTargets and Therapy. Volume 12. 5281–5291. 25 indexed citations
10.
Wang, Xiangyang, et al.. (2018). Marital status and survival in patients with rectal cancer: An analysis of the Surveillance, Epidemiology and End Results (SEER) database. Cancer Epidemiology. 54. 119–124. 51 indexed citations
11.
Yang, Lehe, Youqun Xiang, Wanle Hu, et al.. (2018). L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway. Cancer Management and Research. Volume 10. 565–581. 14 indexed citations
12.
Hu, Wanle, et al.. (2018). β-Ionone-Derived Curcumin Analogs as Potent Anti-Inflammatory Agents. Pharmaceutical Chemistry Journal. 51(10). 902–906. 8 indexed citations
13.
Chen, Suping, et al.. (2017). MicroRNA-141 Is Involved in Ulcerative Colitis Pathogenesis via Aiming at CXCL5. Journal of Interferon & Cytokine Research. 37(9). 415–420. 18 indexed citations
14.
Hu, Yan, Chengguang Zhao, Hailun Zheng, et al.. (2017). A novel STAT3 inhibitor HO-3867 induces cell apoptosis by reactive oxygen species-dependent endoplasmic reticulum stress in human pancreatic cancer cells. Anti-Cancer Drugs. 28(4). 392–400. 23 indexed citations
15.
Zheng, Hailun, Hong Huang, Lulu Zhang, et al.. (2017). Nifuratel, a novel STAT3 inhibitor with potent activity against human gastric cancer cells. Cancer Management and Research. Volume 9. 565–572. 24 indexed citations
16.
Zheng, Hailun, Wanle Hu, Bin Zhou, et al.. (2017). Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer. OncoTargets and Therapy. Volume 10. 1767–1776. 35 indexed citations
17.
Hu, Wanle, Hailun Zheng, Zhiguo Liu, et al.. (2016). Curcumin sensitizes human gastric cancer cells to 5-fluorouracil through inhibition of the NF&kappa;B survival-signaling pathway. OncoTargets and Therapy. Volume 9. 7373–7384. 28 indexed citations
18.
Jin, Chun, et al.. (2015). Activation of IRE1α-XBP1 pathway induces cell proliferation and invasion in colorectal carcinoma. Biochemical and Biophysical Research Communications. 470(1). 75–81. 64 indexed citations
19.
20.
Zhu, Lili, et al.. (2013). [Antitumor effect of capsaicin on colorectal carcinoma xenograft in nude mice].. PubMed. 35(4). 256–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhan‐Qi Cao Breakdown of academic impact, for papers by Leri S. Faried Breakdown of academic impact, for papers by Lianxin Liu Breakdown of academic impact, for papers by Grégory Tufo Breakdown of academic impact, for papers by Rishi K. Gara Breakdown of academic impact, for papers by Hareesh B. Nair Breakdown of academic impact, for papers by Darko Castven Breakdown of academic impact, for papers by Sima Mansoori Derakhshan
Rankless by CCL
2026